Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
Avanos (AVNS) Q2 Earnings Top Estimates, Gross Margin Contracts
01:56pm, Thursday, 01'st Aug 2024
Strength in Avanos' (AVNS) Digestive Health segment drives its second-quarter performance.
Avanos Medical, Inc. (AVNS) Q2 2024 Earnings Call Transcript
01:35pm, Wednesday, 31'st Jul 2024
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Scott Galovan - SVP, Strategy & Corporate Development Joe Woody - Chief Executive Offic
Avanos Medical (AVNS) Beats Q2 Earnings and Revenue Estimates
09:21am, Wednesday, 31'st Jul 2024
Avanos Medical (AVNS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.24 per share a year ago.
Avanos Medical, Inc. Announces Second Quarter 2024 Results
07:00am, Wednesday, 31'st Jul 2024
ALPHARETTA, Ga. , July 31, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2024 financial results.
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
01:46pm, Friday, 26'th Jul 2024
Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
06:14pm, Wednesday, 24'th Jul 2024
ALPHARETTA, Ga. , July 24, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2024 on
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
07:00am, Monday, 01'st Jul 2024
ALPHARETTA, Ga. , July 1, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
Natixis Advisors L.P. Makes New Investment in Avanos Medical, Inc. (NYSE:AVNS)
04:56am, Monday, 20'th May 2024
Natixis Advisors L.P. bought a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and
Avanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply Chain
07:15am, Monday, 13'th May 2024
ALPHARETTA, Ga. , May 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sigfrido (Sig) Delgado has been appointed senior vice president, integrated supply chain.
Avanos Medical, Inc. (AVNS) Q1 2024 Earnings Call Transcript
08:37am, Sunday, 05'th May 2024
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2024 Earnings Conference Call May 2, 2024 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy & Corporate Development Joe Woody - Chief
Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
02:16pm, Friday, 03'rd May 2024
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)
05:26am, Friday, 03'rd May 2024
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share from continuing operations, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.13 per sh
Avanos Medical (AVNS) Q1 Earnings Lag Estimates
09:31am, Thursday, 02'nd May 2024
Avanos Medical (AVNS) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.27 per share a year ago.
Avanos Medical, Inc. Announces First Quarter 2024 Results
07:00am, Thursday, 02'nd May 2024
ALPHARETTA, Ga. , May 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results.
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
11:16am, Thursday, 25'th Apr 2024
ALPHARETTA, Ga. , April 25, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on
